311
Editorial
‘Selling sickness: influence on influence’, what constitutes good prescribing in 2010?
J. W. Foppe van Mil and Martine E. C. van Eijk
312-313
Editorial
A note of thanks
J. W. Foppe van Mil
314-321
Review Article
Pharmacotherapeutic review and update of idiopathic nephrotic syndrome in children
Silvia Manrique-Rodríguez, Cecilia M. Fernandez-Llamazares and Maria Sanjurjo-Saez
322-328
Short Research Paper
Detection of adverse drug reactions through the minimum basic data set
Antonio Salmerón-García, José Cabeza Barrera, Maria José Vergara Pavón, Eva Román Márquez and Sol Cortés de Miguel, et al.
329-333
Short Research Report
Screening for pre-hypertension and elevated cardiovascular risk factors in a Thai community pharmacy
Juraporn Pongwecharak and Tarakamon Treeranurat
334-338
Short Research Report
Views of parents and pharmacists following participation in a paediatric pharmacovigilance study
Mansour Tobaiqy, Derek Stewart, Peter J. Helms, Christine M. Bond and Amanda Jane Lee, et al.
339-342
Short Research Report
Community pharmacists’ views on adverse drug reactions reporting in Malaysia: a pilot study
Kang-Nee Ting, Dane Michael Stratton-Powell and Claire Anderson
343-346
Short Research Report
Knowledge and attitudes of American pharmacists concerning sulfonamide allergy cross-reactivity
Geoffrey C. Wall, Jane E. DeWitt, Sally Haack, Anisa Fornoff and Darla K. Eastman, et al.
347-349
Case Report
Substitution of corticosteroid with everolimus after lung transplantation: a pediatric case report
Thibaut Caruba, Vanida Brunie, Véronique Bousseau, Romain Guillemain and Patrice Prognon, et al.
350-352
Case Report
Highly effective treatment with tacrolimus ointment in an adolescent with oral graft-versus-host disease
T. Bauters, V. Bordon, V. Van de Velde, S. Van Lancker and H. Robays, et al.
353-361
Research Article
Use of simulated patients to assess the clinical and communication skills of community pharmacists
Marjorie C. Weiss, Anneka Booth, Bethan Jones, Sarah Ramjeet and Eva Wong
362-372
Research Article
Classification of drug-related problems with new prescriptions using a modified PCNE classification system
Patrick M. Eichenberger, Markus L. Lampert, Irene Vogel Kahmann, J. W. Foppe van Mil and Kurt E. Hersberger
373-380
Research Article
Cardiovascular risk screening program in Australian community pharmacies
Gregory M. Peterson, Kimbra D. Fitzmaurice, Helen Kruup, Shane L. Jackson and Rohan L. Rasiah
381-385
Research Article
Community pharmacists’ perceptions of medicines use reviews and quality assurance by peer review
Geoffrey Harding and Michael Wilcock
386-393
Research Article
Access to children’s medicines in the United Kingdom, Australia and New Zealand in 1998, 2002 and 2007
Rajan Ragupathy, June Tordoff, Pauline Norris and David Reith
394-403
Research Article
Evaluating categorisation and clinical relevance of drug-related problems in medication reviews
Anne Gerd Granas, Christian Berg, Vidar Hjellvik, Cecilie Haukereid and Arvid Kronstad, et al.
404-410
Original Research
Implementation of guidelines for sequential therapy with fluoroquinolones in a Belgian hospital
Franky Buyle, Dirk Vogelaers, Renaat Peleman, Georges Van Maele and Hugo Robays